Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health
Nanopath will develop & commercialize a biosensing platform that aims to transform how women’s pelvic & gynecologic infections are diagnosed.
Read More
Search Results for: liver disease
Personalis & BC Cancer Assess Benefits of ctDNA for Colorectal, Pancreatic Cancers
Personalis and BC Cancer will deploy a personalized liquid biopsy-based assay for a study of patients with colorectal and pancreatic cancers.
Read More
BD & Accelerate Diagnostics Collaborate on Rapid Test Distribution
BD will offer Accelerate Diagnostic’s rapid testing solution for antibiotic resistance and susceptibility, which provides results in hours.
Read More
Keystone Labs Expands In-House Testing for Hepatitis & HIV Panels
Keystone Laboratories will now be testing hepatitis and HIV panels at its in-house lab located in Asheville, North Carolina.
Read More
Portable Diagnostic Detects SARS-CoV-2 RNA & Antibodies Simultaneously
A new POC diagnostic device can simultaneously detect the presence of both SARS-CoV-2 RNA & antibodies against the virus in saliva.
Read More